Eton Pharmaceuticals logo
Eton Pharmaceuticals ETON
$ 10.5 0.67%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Eton Pharmaceuticals Financial Statements 2011-2024 | ETON

Annual Financial Statements Eton Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

114 M 106 M 93.3 M 217 M 122 M 39.8 M - - - - - - -

Shares

25.6 M 25.1 M 25.2 M 24.3 M 17.8 M 6.42 M - - - - - - -

Historical Prices

4.46 4.2 3.7 8.92 6.66 6.1 - - - - - - -

Net Income

-936 K -9.02 M -1.96 M -28 M -18.3 M -12.7 M - - - - - - -

Revenue

31.6 M 21.3 M 21.8 M 39 K 959 K - - - - - - - -

Cost of Revenue

10.6 M 6.93 M 2.83 M 436 K 453 K - - - - - - - -

Gross Profit

21.1 M 14.3 M 19 M -397 K 506 K - - - - - - - -

Operating Income

-1.19 M -8.26 M -1.5 M -27.1 M -18.6 M -10.3 M - - - - - - -

Interest Expense

1.06 M 955 K 1.04 M 884 K 98 K - - - - - - - -

EBITDA

-291 K -6.49 M -1.03 M -26.8 M -18.2 M -10.3 M - - - - - - -

Operating Expenses

22.3 M 22.6 M 20.5 M 26.7 M 19.1 M 10.3 M - - - - - - -

General and Administrative Expenses

18.9 M 18.6 M 14.3 M 12.6 M 7.55 M 4.69 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Eton Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

25.9 K 25.8 K 25.8 K 25.7 M 25.7 K 25.6 K 25.5 K 25.4 M 25.4 M 25.1 M 25.3 M 24.6 M 25.3 M 25.2 K 24.5 M 24.3 M 21.1 M 21 M 18.1 M 17.9 M 17.9 M 17.7 K 17.5 M 11.6 M 5.62 M 4.79 M 3.55 M 6 M 3.5 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

627 K -3.04 M -811 K - -579 K 4.56 M -2.66 M - -3.04 M -1.56 M -5.33 M - -6.09 M -2.02 M 5.12 M - -6.5 M -4.73 M -9.05 M -2.7 M -4.96 M -3.25 M -7.41 M -3.73 M -2.91 M -3.08 M -3.02 M - -2.8 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

10.3 M 9.07 M 7.97 M - 7.03 M 12 M 5.3 M - 3.22 M 7.36 M 2.18 M - 775 K 3.07 M 11.9 M - -161 K 20 K 99 K 459 K 500 K 500 K 500 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

4.02 M 3.45 M 2.96 M - 2.62 M 2.32 M 1.96 M - 1.2 M 2.74 M 849 K - 654 K 174 K 1.59 M - 144 K 28 K 102 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

6.3 M 5.63 M 5.01 M - 4.4 M 9.68 M 3.35 M - 2.02 M 4.61 M 1.33 M - 121 K 2.89 M 10.3 M - -17 K -8 K -3 K - 500 K 500 K 500 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

509 K -2.94 M -800 K - -548 K 3.88 M -2.53 M - -2.9 M -1.34 M -5.09 M - -5.85 M -2.32 M 5.36 M - -6.27 M -4.54 M -8.88 M - -5.04 M -3.35 M -7.55 M - -2.37 M -2.7 M -2.96 M - -2.77 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

211 K - 238 K - 267 K - 265 K - 699 K 466 K 247 K - 766 K 513 K 264 K - 617 K 386 K 195 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

521 K -2.92 M -548 K - -539 K 3.89 M -2.32 M - -2.88 M -1.32 M -4.91 M - -5.82 M -2.3 M 5.45 M - -5.78 M -4.21 M -8.72 M - -4.74 M -3.17 M -7.5 M - -2.33 M -2.67 M -2.95 M - -2.77 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

5.79 M 8.56 M 5.81 M - 4.95 M 5.8 M 5.88 M - 4.91 M 5.95 M 6.41 M - 5.97 M 5.22 M 4.94 M - 6.26 M 4.53 M 8.88 M 2.66 M 5.04 M 3.35 M 8.05 M 2.29 M 2.37 M 2.7 M 2.96 M - 2.77 M - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

5.29 M 5.59 M 5.16 M - 4.34 M 4.67 M 5.34 M - 4.17 M 5.26 M 4.8 M - 3.29 M 3.23 M 4.06 M - 3.43 M 2.92 M 2.61 M - 1.62 M 1.91 M 1.59 M - 830 K 990 K 1.69 M - 1.21 M - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency